Cargando…

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis

Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome with a global prevalence. Impaired gut barrier function caused by an unhealthy diet plays a key role in disrupting the immune-metabolic homeostasis of the gut-liver axis (GLA), leading to NAFLD. Therefore, die...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Weifeng, Zhou, Ying, Tsao, Rong, Dong, Huanhuan, Zhang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159374/ https://www.ncbi.nlm.nih.gov/pubmed/35662935 http://dx.doi.org/10.3389/fnut.2022.861854

Ejemplares similares

Folic acid ameliorates alcohol-induced liver injury via gut–liver axis homeostasis
por: Zhang, Huaqi, et al.
Publicado: (2022)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
por: Tokuhara, Daisuke
Publicado: (2021)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
por: Day, Kaitlin, et al.
Publicado: (2021)

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
por: Maestri, Marta, et al.
Publicado: (2023)

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
por: Zambon Azevedo, Vittoria, et al.
Publicado: (2022)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota
por: Cao, Feiwei, et al.
Publicado: (2023)

Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
por: Yang, Xiaoying, et al.
Publicado: (2022)

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
por: Meroni, Marica, et al.
Publicado: (2022)

Editorial: Nutrition in prevention and management of non-alcoholic fatty liver disease
por: Kouvari, Matina, et al.
Publicado: (2023)

Effects of beer, wine, and baijiu consumption on non-alcoholic fatty liver disease: Potential implications of the flavor compounds in the alcoholic beverages
por: Zhou, Yabin, et al.
Publicado: (2023)

Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
por: Zhang, Lijia, et al.
Publicado: (2022)

Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
por: Wu, Qiongbo, et al.
Publicado: (2022)

Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
por: Cao, Chujin, et al.
Publicado: (2023)

Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression
por: Balbuena, Emilio, et al.
Publicado: (2022)

Mini review: STING activation during non-alcoholic fatty liver disease
por: Li, Honggui, et al.
Publicado: (2023)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
por: Hu, Yu-long, et al.
Publicado: (2023)

Corilagin prevents non-alcoholic fatty liver disease via improving lipid metabolism and glucose homeostasis in high fat diet-fed mice
por: Liao, Mingjuan, et al.
Publicado: (2022)

Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis
por: Lin, Pei, et al.
Publicado: (2015)

Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
por: Musazadeh, Vali, et al.
Publicado: (2022)

Association Between Dietary Fiber Intake and Non-alcoholic Fatty Liver Disease in Adults
por: Zhao, Huimin, et al.
Publicado: (2020)

Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease
por: Zhang, Dan, et al.
Publicado: (2022)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Complex Dietary Topologies in Non-alcoholic Fatty Liver Disease: A Network Science Analysis
por: Xia, Yang, et al.
Publicado: (2020)

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Yin, Cong, et al.
Publicado: (2021)

Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
por: Sabirin, Faezah, et al.
Publicado: (2022)

Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease
por: Hao, Shiqi, et al.
Publicado: (2022)

Dietary Resistant Starch From Potato Regulates Bone Mass by Modulating Gut Microbiota and Concomitant Short-Chain Fatty Acids Production in Meat Ducks
por: Zhang, Huaiyong, et al.
Publicado: (2022)

Dietary Goji Shapes the Gut Microbiota to Prevent the Liver Injury Induced by Acute Alcohol Intake
por: Guo, Lin, et al.
Publicado: (2022)

Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis
por: Li, Hang-Yu, et al.
Publicado: (2023)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2022)

Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
por: Yao, Nan, et al.
Publicado: (2022)

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Houttu, Veera, et al.
Publicado: (2021)

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2022)

Variation in Lifestyle-Related Behavior Among Obese Indian Patients With Non-alcoholic Fatty Liver Disease
por: Arora, Charu, et al.
Publicado: (2021)

Nutrient patterns and non-alcoholic fatty liver disease in Iranian Adul: A case-control study
por: Salehi-sahlabadi, Ammar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pno2nsrpeopg4kk6r9o5trvbj7